Malignant Mesothelioma: A Study of Sixty-Six Cases



Similar documents
Mesothelioma: Questions and Answers

Surgeons Role in Symptom Management. A/Prof Cliff K. C. Choong Consultant Thoracic Surgeon Latrobe Regional Hospital GIPPSLAND

Survey of Mesothelioma Associated with Asbestos Exposure in Japan

Asbestos Related Diseases

Male. Female. Death rates from lung cancer in USA

Mesothelioma , The Patient Education Institute, Inc. ocft0101 Last reviewed: 03/21/2013 1

Asbestos and your lungs

Asbestos Health Risks. Dr Andrew Pengilley Acting Chief Health Officer

Malignant Mesothelioma

Malignant Mesothelioma

Health Effects of Asbestos Exposure

Asbestos Related Diseases. Asbestosis Mesothelioma Lung Cancer Pleural Disease. connecting raising awareness supporting advocating

Disease/Illness GUIDE TO ASBESTOS LUNG CANCER. What Is Asbestos Lung Cancer? Telephone

بسم هللا الرحمن الرحيم

Health effects of occupational exposure to asbestos dust

Clinical cases in Malignant Pleural Mesothelioma: Adherence to the ESMO Clinical Practice Guidelines

International Journal of Case Reports in Medicine

Summary of treatment benefits

ASBESTOS DISEASES. Dr Alastair Robertson

FREQUENTLY ASKED QUESTIONS about asbestos related diseases

EFFECT OF CHILDREN'S AGE AND LIFE EXPECTATION ON MESOTHELIOMA RISK 1

Neoplasms of the LUNG and PLEURA

PATTERNS OF MORTALITY IN ASBESTOS FACTORY WORKERS IN LONDON*

Diagnostic Challenge. Department of Pathology,

NISG Asbestos. Caroline Kirton

ASBESTOS EXPOSURE AND SARCOMATOID MALIGNANT PLEURAL MESOTHELIOMA Gorantla Sambasivarao 1, Namballa Usharani 2, Tupakula Suresh Babu 3

HANDLING LUNG CANCER CLAIMS

What is Mesothelioma?

Sir William Osler: Listen to the patient; the patient tells you everything.

WORKPLACE SAFETY AND INSURANCE APPEALS TRIBUNAL DECISION NO. 171/08

Malignant Mesothelioma Among Employees of a Connecticut Factory that Manufactured Friction Materials Using Chrysotile Asbestos

Influence of Fiber Type, Size, and Number in Human Disease: Conclusions from Fiber Burden Analysis

NHS Barking and Dagenham Briefing on disease linked to Asbestos in Barking & Dagenham

INTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCER Prospective Mesothelioma Staging Project

Francine Lortie-Monette, MD, MSc, CSPQ, MBA Department of Epidemiology and Biostatistics University of Western Ontario 2003

Lung Cancer: Diagnosis, Staging and Treatment

Malignant Pleural Mesothelioma Diagnosed by Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration

Epidemiology, Staging and Treatment of Lung Cancer. Mark A. Socinski, MD

Asbestos related disease compensation. no-one can change the past, but one of us could change your future

Primary -Benign - Malignant Secondary

Actuarial projections for mesothelioma: an epidemiological perspective Mark Clements, Geoffrey Berry and Jill Shi

Sternotomy and removal of the tumor

Asbestos and the diseases it causes

Asbestos Diseases. What Is Asbestos?

WORKPLACE SAFETY AND INSURANCE APPEALS TRIBUNAL DECISION NO. 1557/14

Update on Mesothelioma

Asbestos related cancers

Uses and Abuses of Pathology in Asbestos-exposed Populations

Exploring the Role of Vitamins in Achieving a Healthy Heart

Current Usage and Health Significance of the Modern Use of Chrysotile Products: Review of Recently Published Evidence

BY THE NUMBERS: THE FUTURE OF MESOTHELIOMA IN AMERICA

HEALTH CARE FOR EXPOSURE TO ASBESTOS The SafetyNet Centre for Occupational Health and Safety Research Memorial University

OCCUPATIONAL LUNG CANCER

Asbestos Disease: An Overview for Clinicians Asbestos Exposure

Asbestos Brochure. Jim Wyatt - jwyatt@hamers.com Stephen Ball - sball@hamers.com. Freephone:

Scientific Update on Safe Use of Asbestos. Robert P. Nolan, PhD International Environmental Research Foundation New York, New York

Changing Trends in Mesothelioma Incidence. Hans Weill, M.D. Professor of Medicine Emeritus Tulane University Medical Center

How To Determine The Risk Of Mesothelioma In Brake Workers

Mesothelioma and Asbestos

Asbestos: health effects and risk. Peter Franklin Senior Scientific Officer, EHD Senior Research Fellow, UWA

Cytology : first alert of mesothelioma? Professor B. Weynand, UCL Yvoir, Belgium

Hamers S O L I C I T O R S. Jim Wyatt jwyatt@hamers.com. Freephone: Earls Court, Priory Park, East, Hull HU4 7DY

MORTALITY FROM LUNG CANCER IN ASBESTOS WORKERS

Transcript for Asbestos Information for the Community

MesoPDT. Photodynamic Therapy for malignant pleural mesothelioma ONCO-THAI. Image Assisted Laser Therapy for Oncology

Asbestos and Mesothelioma a briefing document for the Metropolitan Police

Lung cancer and asbestos

Asbestos, Asbestosis, and Lung Cancer

Emerging evidence that the ban on asbestos use is reducing the occurrence of pleural mesothelioma in Sweden

Asbestos Learn more:

Malignant Mesothelioma: an Update

The diagnostic usefulness of tumour markers CEA and CA-125 in pleural effusion

Asbestos & Mesothelioma Cases. Presented by Sara Salger On behalf of Gori, Julian & Associates, P.C., Edwardsville, IL

Survey on the Mortality from Malignant Tumors of Female Asbestos Spinning Workers

Malignant Mesothelioma Versus Metastatic Carcinoma of the Pleura: A CT Challenge

Lessons learned from the Western Australian experience with mesothelioma

Lung Cancer. This reference summary will help you better understand lung cancer and the treatment options that are available.

How To Understand How Cancer Works

L Lang-Lazdunski, A Bille, S Marshall, R Lal, D Landau, J Spicer

by Lee S. Newman, M.D., and Cecile S. Rose, M.D., M.P.H.

Cardiac Masses and Tumors

Incidence of Malignant Pleural Mesothelioma due to Environmental Asbestos Fiber Exposure in the Southeast of Turkey

The Trend in Airborne Asbestos Concentrations at Plants Manufacturing Asbestos-Containing Products in Japan

Mesothelioma and Asbestos

J of Evidence Based Med & Hlthcare, pissn , eissn / Vol. 2/Issue 33/Aug. 17, 2015 Page 5063

B10/S/a Cancer: Malignant Mesothelioma (Adult)

MALIGNANT PLEURAL MESOTHELIOMA TREATED IN CLINIC FOR PULMONARY DISEASES AND TUBERCULOSIS PODHRASTOVI IN TEN-YEAR PERIOD ( FROM 1998 TO 2007 )

Targeting Specific Cell Signaling Pathways for the Treatment of Malignant Peritoneal Mesothelioma

HEALTH EFFECTS. Inhalation

Transcription:

ORIGINAL RESEARCH ARTICLE Tanaffos (2006) 5(4), 59-63 2006 NRITLD, National Research Institute of Tuberculosis and Lung Disease, Iran Malignant Mesothelioma: A Study of Sixty-Six Cases Ali Cheraghvandi 1, Saeid Fallah Tafti 1,2, Shirin Karimi 3,4, Haleh Kosari 1 1 Department of Internal Medicine, 2 Tobacco Prevention and Control Research Center, 3 Department of Clinical Anatomical Pathology, 4 Mycobacteriology Research Center, NRITLD, Shaeed Beheshti University of Medical Sciences and Health Services, TEHRAN-IRAN. ABSTRACT Background: This study was conducted to review the epidemiology, and biochemical data of pleural fluid to assess the potential contribution to occupational risk of patients with malignant mesothelioma (MM) in Iran. Materials and Methods: Hospital files of patients with MM of the pleura in Masih Daneshvari Hospital were reviewed between 1997 and 2004 and were evaluated in a cross-sectional study. Results: 66 patients (49 men and 17 women) with a mean age of 53.8± 4.2 yrs were selected. Probable or known occupational contacts were detected in 8 (12.1%) patients. The diagnosis was confirmed by closed pleural biopsy in 26(39.4%) cases. Statistical analysis showed significant cut-off for LDH and glucose level in pleural fluid analysis. Conclusion: Detailed occupational history must not overemphasize blind biopsy as the first diagnostic approach for MM of pleura and pleural fluid glucose as well as LDH had characteristic levels respectively. (Tanaffos 2006; 5(4): 59-63) Key words: Mesothelioma, Epidemiology, Occupational exposure. INTRODUCTION Malignant Mesothelioma (MM) is an aggressive tumor of serosal surfaces, such as the pleura and the peritoneum (1-3). There is a substantial concern that the increased use of asbestos in developing countries may result in an increase in the number of cases of malignant mesothelioma for many decades to come; unless strong occupational health controls are put in place(4). Although widespread exposure to asbestos is a main recognized factor, however, in most Correspondence to: Fallah Tafti S Address: NRITLD, Shaheed Bahonar Ave, Darabad, TEHRAN 19569, P.O:19575/154, IRAN Email address: saeid_ftafti@yahoo.com Received: 8 May 2006 Accepted: 5 December 2006 instances and situations finding the association between occupation and the disease is difficult. On the other hand, the combination of an unexplained pleural effusion and pleuritic pain should raise the suspicion of MM. Because of the low incidence of constitutional symptoms especially weight loss and fatigability, rare metastasis, extension of tumor by the time of presentation and lack of epidemiologic features of asbestos exposure, MM is rarely considered at the first presentation and the diagnosis is usually delayed for a several months (5). In this article we review the clinical features, biochemical assays of pleural fluid, and accurate diagnostic tools in 66 patients with MM.

60 Malignant Mesothelioma MATERIALS AND METHODS A cross-sectional study during 1997 to 2004 was performed on 66 patients with a documented diagnosis of MM at the National Research Institute of Tuberculosis and Lung Disease. These cases were all biopsy proven cases of MM (based on histological appearance, distribution of tumor by CTscan and in some cases the results of immunohistochemical studies especially calretinin stain). In all cases, the diagnosis of MM was made independent of asbestos exposure history. Information regarding age, sex, occupation and characteristic of biochemical data of pleural effusion (LDH and glucose level) and type of biopsy taken was also obtained. Information regarding the occupational exposure was obtained through review of the medical records. More attention was paid to the occupational asbestos exposure. In our study, statistical analysis was performed on biochemical data of pleural fluid such as LDH and glucose level. RESULTS There were 66 patients of which 49 (74.2%) were males and 17(25.8%) were females with a mean age of 53.8±4.2 yrs. Occupational exposure was detected in only 8(12.1%) cases (Table 1). The predominant cell type was epithelial (75%) and all primary tumors arose from the pleura; 58 patients (87.8%) presented with dyspnea, 43 patients (65.1%) with pleuritic pain, and 39 patients (59%) had experienced coughs. Exudative pleural effusion, thickened pleural and pleural plaque were confirmed in 51(77.2%), 24(36.3%) and 3(4.5%) patients respectively. One-Sample t-test analysis of biochemical data of pleural fluid showed significant cut-off for LDH and pleural glucose. Statistical analysis for biochemical studies of pleural fluid showed that in 25 percent, glucose level was <36mg/dl; in 50 percent <65mg/dl; and in 75 percent <82mg/dl. These measurements for LDH were 370 lu/dl, 650 IU/dl, and 769 IU/dl respectively. One- Sample t-test showed significant ranges of LDH levels between 200 (p=0.00) and 400 IU/dl (p=0.004). The same results were obtained regarding the glucose of pleural fluid which was between 40 (p=0.00) and 50 (p=0.038). Table 1. Occupational data in 66 patients of malignant pleural mesothelioma (1997-2004) Exposure type No. of patients % Housewife 16 24.3 Tradesman 5 7.6 Farmer 7 10.7 Butler 4 6 Military Personnel 2 3 Cement factory worker 8 12.1 Construction works man 8 12.1 Driver 2 3 Fruit market worker 1 1.5 Officer 11 16.7 Shoemakers 2 3 Pathologic diagnosis was confirmed by blind percutaneous needle biopsy in 26 (39.4%) patients (Figure 1). Figure 1. diagnosis open lung biopsy; 39.4 CT-guided biopsy; 6.25 The methods used for the confirmation of pathologic The percentile of glucose and LDH measurement are shown in figure 2, 3. VATS; 13.6 needle biolsy ; 39.4

Cheraghvandi A, et al. 61 Figure 2. Cumulative percentage of glucose values in patients with MM Figure 3. Cumulative percentage of LDH values in patients with MM DISCUSSION It is said that MM is almost always caused by inhalation of asbestos fibers, years before the presentation (6, 7, 8). Furthermore, many studies have examined workers exposed to asbestos (9, 10, 11). In the present study, a significant correlation between occupation and asbestos exposure and MM was not detected. These groups of patients accounting for 85 percent of current series probably include those who were exposed to asbestos unknowingly and incidentally in the myriad of situations in which asbestos fibers are released into the atmosphere in industrialized countries (2, 12). Although a detailed occupational history should alert the clinician to the possibility of mesothelioma as a cause of the patients' symptoms, obtaining an accurate occupational history cannot be overemphasized (13, 14). The importance of detailed occupational history at the first consultation may carry more weight than a history which is elicited after the diagnosis of mesothelioma has been made (2). This case series showed typical MM patients presenting with dyspnea, chest pain, or both. Unlike carcinoma of bronchus, hemoptysis and symptoms due to distal metastases are unusual. The disease is more likely to progress by local extension than hematogenous spread. A chest wall mass, weight loss, abdominal pain, and ascites (due to peritoneal involvement) are less common presentations (1,8). In non of the patients in this case series, symptomatic metastasis was confirmed. The initial approach to diagnosis depends on the presenting feature. For instance, chest wall pain, unilateral pleural thickening, and undiagnosed pleural effusion, all raise the possibility of mesothelioma. Although CT-scan findings have a key role in the diagnosis of mesothelioma (such as pleural plaques or thickening and nodularity of the pleura) pathological confirmation is recommended, unless the patient is frail or has extremely advanced disease (2,3). In the past, closed pleural needle biopsy (CPNB) was thought to deliver insufficient tissue to allow a definite diagnosis of MM. The diagnostic yield for CPNB has generally been reported as 20 to 30 percent (4,5). However, we found that a blind directed CPNB using an Abram's needle produced a yield of % 40. A CT-guided approach gave a yield of % 6.25. Video-assisted thoracoscopy (VATS) has been used universally to obtain samples for diagnosing MM of the pleura. Diagnostic yields of 60 to 75 percent have been reported (15). However, the use of this procedure is not cost effective especially in third world countries and CPNB is suggested to be performed prior to open lung biopsy

62 Malignant Mesothelioma (OLB) in patients in whom a definitive diagnosis of MM of the pleura is required (16). The steadily increasing incidence of MM of the pleura during 1997-2004 in our institution corresponds with the rapid growth period from late 1970. Industries such as iron, steel construction, and pharmaceuticals grew quickly, and the household electrical products as well as the petrochemical industry developed with this economic growth. The use and the amount of asbestos expanded, but with some factors such as immunohistochemical staining technique, the diagnosis of MM has also become more accurate than before (2, 3, 14). Statistical analysis showed that there was a strong association between glucose level of 40-50 mg /dl and LDH level of 200-400mg/dl and MM of the pleura. Although these indices were not specifically addressed to MM of the pleura they had a very important role in deciding for surgical biopsy. But even then, the diagnosis remains elusive. Nevertheless, to our knowledge, such a systematic approach on large unselected patients with MM has not been previously reported. There are a number of limitations in the present study. First of all, the sample tissues were not examined for detection of asbestos bodies and fibers by chemical and staining or energy dispersive x-ray analysis. For this reason conclusions may not be representative of all individuals exposed to dust, occupationally (17). Secondly, historical information obtained by the patient interview is subject to recall bias for events that occurred decades ago. This may explain the absence of %88 cases of reported exposure to commercial asbestos fiber in our study. Thirdly, there is a possibility that exposure might be induced by environmental factors other than occupation (18). However, we think that this is unlikely, since a number of investigators using somewhat more sensitive, and sophisticated methods found no correlation between the concentration of asbestos fiber and the risk of MM (15). A more troublesome issue in this article is the fact that we could not prove any correlation between MM and the type of occupation (15, 16). In this regard we think that these patients were exposed to asbestos unknowing and incidentally in the myriad of situations, in which asbestos fibers are released into the atmosphere. Thus, we recommend that prompt referral to a pulmonologist should be done for any patient in whom early assessment raises the possibility of MM. REFERENCES 1. Luo S, Liu X, Mu S, Tsai SP, Wen CP. Asbestos related diseases from environmental exposure to crocidolite in Dayao, China. I. Review of exposure and epidemiological data. Occup Environ Med 2003; 60 (1): 35-41; discussion 41-2. 2. Villena Garrido V, Lopez Encuentra A, Echave-Sustaeta J, Alvarez Martinez C, Rey Terron L, Sotelo MT, et al. Pleural mesothelioma: experience with 62 cases in 9 years. Arch Bronconeumol 2004; 40 (5): 203-8. 3. Lopes C, Sotto-Mayor R, Teixeira E, Almeida A. Malignant mesothelioma: A ten years experience. Rev Port Pneumol 2005; 11 (6 Suppl 1): 16-8. 4. Takahashi K. Emerging health effects of asbestos in Asia. In: Proceedings of the Global Asbestos Congress, Tokyo, 2004: 2. 19 21 5. Peto J, Hodgson JT, Matthews FE, Jones JR. Continuing increase in mesothelioma mortality in Britain. Lancet 1995; 345 (8949): 535-9. 6. Hubbard R. The aetiology of mesothelioma: are risk factors other than asbestos exposure important? Thorax 1997; 52 (6): 496-7. 7. McDonald JC. Health implications of environmental exposure to asbestos. Environ Health Perspect 1985; 62: 319-28. 8. Yates DH, Corrin B, Stidolph PN, Browne K. Malignant mesothelioma in south east England: clinicopathological experience of 272 cases. Thorax 1997; 52 (6): 507-12. Erratum in: Thorax 1997; 52 (11): 1018.

Cheraghvandi A, et al. 63 9. Elmes PC, Simpson JC. The clinical aspects of mesothelioma. Q J Med 1976; 45 (179): 427-49. 10. Hillerdal G. Malignant mesothelioma 1982: review of 4710 published cases. Br J Dis Chest 1983; 77 (4): 321-43. 11. Renshaw AA, Dean BR, Antman KH, Sugarbaker DJ, Cibas ES. The role of cytologic evaluation of pleural fluid in the diagnosis of malignant mesothelioma. Chest 1997; 111(1):106-9. 12. Boutin C, Rey F. Thoracoscopy in pleural malignant mesothelioma: a prospective study of 188 consecutive patients. Part 1: Diagnosis. Cancer 1993; 72 (2): 389-93. 13. Scott B, Mukherjee S, Lake R A, Robinson BWS. Malignant mesothelioma. In: Hanson H, ed. Textbook of lung cancer. London: Martin Dunitz, 2000:273-93. 14. Pantanowitz L, Otis CN. Malignant mesothelioma. N Engl J Med 2006; 354 (3): 305-7. 15. Robinson, Lake. R. A. Advanced in Malignant Mesothelioma. NEJM 2003; 353: 1591-1603. 16. Goldberg M, Luce D. Can exposure to very low levels of asbestos induce pleural mesothelioma? Am J Respir Crit Care Med 2005; 172 (8): 939-40. 17. Hillerdal G. Mesothelioma: cases associated with nonoccupational and low dose exposures. Occup Environ Med 1999; 56 (8): 505-13. 18. de klerk NH, Musk AM.Epidemiology of mesothelioma. In: Robinson B W S, ChAhnian P eds. Mesothelioma London: Martin Dunitz, 2002: 339-50.